Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapyEva Barragán, Óscar Fuster, Dolors Colomer et al.|Haematologica|2011Cited by 65
Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐<scp>PCR</scp>of immunoglobulin genes in multiple myeloma. Results from a<scp>GEM</scp>/<scp>PETHEMA</scp>studyJoaquín Martínez‐López, Elena Fernández‐Redondo, Ramón García‐Sánz et al.|British Journal of Haematology|2013Cited by 29
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan Manuel Alonso‐Domínguez, Joaquín Martínez‐López, Luis Felipe Casado et al.|PLoS ONE|2017Cited by 10
Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma.Joaquín Martínez‐López, Juan José Lahuerta, Ramón García‐Sánz et al.|Journal of Clinical Oncology|2013Cited by 2
Under Scope of the Current Redefinition Process of Optimal Response in Multiple Myeloma: Assesment of Molecular Response by Fluorescent PCR of Ig Genes Has Similar Applicability and Prognosis Impact to Immunophenotypic Response. (A GEM/PETHEMA study),Elena Fernandez Redondo, Juan José Lahuerta, Joaquín Martínez‐López et al.|Blood|2011Cited by 1